Advanced Glycation Endproducts in Diabetes and Diabetic Complications

• Autores: Helen Vlassara, Gary E. Striker
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 42, Nº. 4, 2013 (Ejemplar dedicado a: Acute and Chronic Complications of Diabetes), págs. 697-719
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • This review presents insights from studies of advanced glycation end products (AGEs) in humans and mice. Although the emphasis is on the effects of exogenous AGEs and the suppression of specific host defense mechanisms, AGEs are also formed intracellularly, where they may contribute to several normal intracellular functions. It is only when the overall levels of AGEs in the extracellular and the intracellular spaces exceeds the ability of the native antioxidant (and AGE) defenses that they pose a problem.